Background Patients undergoing thoracoscopic pulmonary resection are prone to moderate-to-severe acute postoperative pain, ...
As enterprises move from reactive analytics to AI agents, Google Cloud's data chief details new metadata, cross-cloud, and ...
The news is quite shocking. Seattle City Light reports that three companies are exploring four large-scale data center sites in various parts of the public utility’s service area. The centers range ...
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.
The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with two major industry players already taking part in a pilot program.
A single-arm, multi-center phase II study of tislelizumab combined with lenvatinib and GEMOX as conversion therapy in potentially resectable locally advanced biliary tract cancer (ZSAB-TransGOLP): A ...
Through a new pilot program announced this week, the Food and Drug Administration will use artificial intelligence and cloud computing to monitor clinical trial data in real time, an effort that could ...
A licensed attorney with nearly a decade of experience in content production, Valerie Catalano knows how to help readers digest complicated information about the law ...
“Listening is not the act of hearing the words spoken; it is the art of understanding the meaning behind those words.” –Simon Sinek Speaking is a critical life skill that we’re taught from birth. In ...